PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin

NCT04021277 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped Business reason

Conditions

Solid Tumor
Colorectal Cancer

Interventions

DRUG: 20 uL/kg PS101
DRUG: 40 uL/kg PS101
DEVICE: Ultrasound

Sponsor

EXACT Therapeutics AS